Pharma Journalist -

Roche asserted that it has received FDA clearance for the cobas Factor II and Factor V Test for use on the cobas 4800 system. The test enables laboratories to simultaneously evaluate …
Read More...

FDA has approved a certain Erleada for the treatment of patient inflicted with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the approval of ERLEADA (apalutamide), a next-generation androgen receptor inhibitor for the treatment of…
Read More...

Mallinckrodt plc  confirmed the enrollment of first patient for the company's Phase 1 study evaluating the safety and tolerance of ExpressGraft C9T1 skin tissue in the treatment of…
Read More...

Division of Valeant Pharmaceuticals International, Inc., Ortho Dermatologics asserted that the U.S Food and Drug Administration accepted the New Drug Application for JEMDEL  …
Read More...

PharmaMar forays into an exclusive licensing agreement with Seattle Genetics ensuring access to certain PharmaMar proprietary molecules for the development and commercialization of…
Read More...

Amgen asserted that the Oncologic Drugs Advisory Committee of the U.S Food and Drug Administration will assess the data supporting the BLINCYTO supplemental Biologics License…
Read More...

Philadelphia, PA (Feb 14) IQPC’s Pharma Anti-Counterfeiting & Brand Protection Summit, the nation’s foremost event addressing innovative solutions to manage and create your brand…
Read More...

In the run up to the 3rd annual Pre-Filled Syringes West Coast Conference (4 – 5 June, San Diego, US), SMi Group caught up with Paul Upham, Senior Principal, Genentech to discuss common…
Read More...

Ace RNA medicines company, Arcturus Therapeutics asserted the appointment of Dr. Christine Esau, Senior Director of Translational Research, as Vice President of Research and…
Read More...